TipRanks

Mark J. Rosenblum Insider Profile

11 Followers
Mark J. Rosenblum, CFO at Decoy Therapeutics, holds 11.36K shares in Decoy Therapeutics (Ticker: DCOY), holds 113.77K shares in Advaxis (Ticker: ADXS).
tipranks
Mark J. Rosenblum

Mark J. Rosenblum
Decoy Therapeutics (DCOY)
CFO

Ranked #24,128 out of 109,349 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

+11.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$12K
100.00%
A breakdown of Mark J. Rosenblum's holdings

Insider Roles

Decoy Therapeutics
(DCOY)
CFO
Roles that Mark J. Rosenblum holds in companies

Most Profitable Insider Trade

Stock:
Decoy Therapeutics
(DCOY)
Rating:Informative Buy
Date:Feb 13, 2020 - Feb 13, 2021
Return:+192.10%
The most profitable trade made by Mark J. Rosenblum

Mark J. Rosenblum's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Decoy Therapeutics
Sep 02, 2026
CFO
Uninformative Buy
―
$12.16K
ADXS
Advaxis
Feb 04, 2014
―
Uninformative Buy
―
$68.61K
List of latest transactions for each holding click on a transaction to see Mark J. Rosenblum's performance on stock

Mark J. Rosenblum insider profile FAQ

What is the percentage of profitable transactions made by Mark J. Rosenblum?
The percentage of profitable transactions made by Mark J. Rosenblum is 33%.
    What is the average return per transaction made by Mark J. Rosenblum?
    The average return per transaction made by Mark J. Rosenblum is 11.80%.
      What stocks does Mark J. Rosenblum hold?
      Mark J. Rosenblum holds: DCOY, ADXS stocks.
        What was Mark J. Rosenblum’s latest transaction?
        Mark J. Rosenblum latest transaction was an Uninformative Buy of ―.
          What was Mark J. Rosenblum's most profitable transaction?
          Mark J. Rosenblum’s most profitable transaction was an Informative Buy of DCOY stock on February 13, 2020. The return on the trade was 192.10%.
            What is Mark J. Rosenblum's role in Decoy Therapeutics?
            Mark J. Rosenblum's role in Decoy Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.